IP Library › Granted Patent US 11,407,784
Granted Patent B2
US 11,407,784 · App. 16/709,491 · Granted Aug 9, 2022

Capture purification processes for proteins expressed in a non-mammalian system

Inventors: Joseph Edward Shultz (Oberwil, CH); Roger Hart (Needham, MA)
Assignee: Amgen Inc.
C07K1/22C07K1/145C07K1/18C07K1/32C07K16/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,407,784
App. No.
16/709,491
Granted
Aug 9, 2022
Kind
B2
Abstract

Methods of purifying proteins expressed in non-mammalian expression systems in a non-native soluble form directly from cell lysate are disclosed. Methods of purifying proteins expressed in non-mammalian expression systems in a non-native limited solubility form directly from a refold solution are also disclosed. Resin regeneration methods are also provided.

Claims (24)

1. A method of purifying a protein expressed in a non-native soluble form in a non-mammalian expression system, the method comprising:

(a) lysing a non-mammalian cell in which the protein is expressed in a nonnative soluble form to generate a cell lysate;

(b) filtering the cell lysate;

(c) contacting the filtered cell lysate with a separation matrix under conditions suitable for the protein to associate with the separation matrix;

(d) washing the separation matrix;

(e) eluting the protein from the separation matrix; and

(f) isolating the protein after elution.

2. The method of claim 1 , wherein the non-mammalian expression system comprises bacteria cells.

3. The method of claim 2 , further comprising refolding the isolated protein to its native form.

4. The method of claim 2 , wherein the separation matrix is a nonaffinity resin selected from the group consisting of: ion exchange, mixed mode, and a hydrophobic interaction resin.

5. The method of claim 2 , wherein the separation matrix is an affinity resin selected from the group consisting of: Protein A, Protein G, and a synthetic mimetic affinity resin.

6. The method of claim 2 , wherein the protein is a complex protein.

7. The method of claim 6 , wherein the complex protein is selected from the group consisting of: a multimeric protein, an antibody, and an Fc fusion protein.

8. The method of claim 1 , wherein the non-mammalian expression system comprises yeast cells.

9. The method of claim 8 , further comprising refolding the isolated protein to its native form.

10. The method of claim 8 , wherein the separation matrix is a nonaffinity resin selected from the group consisting of: ion exchange, mixed mode, and a hydrophobic interaction resin.

11. The method of claim 8 , wherein the separation matrix is an affinity resin selected from the group consisting of: Protein A, Protein G, and a synthetic mimetic affinity resin.

12. The method of claim 8 , wherein the protein is a complex protein.

13. The method of claim 12 , wherein the complex protein is selected from the group consisting of: a multimeric protein, an antibody, and an Fc fusion protein.

14. The method of claim 1 , further comprising refolding the isolated protein to its native form.

15. The method of claim 14 , wherein the protein is a complex protein.

16. The method of claim 15 , wherein the complex protein is selected from the group consisting of: a multimeric protein, an antibody, and an Fc fusion protein.

17. The method of claim 14 , wherein the separation matrix is a nonaffinity resin selected from the group consisting of: ion exchange, mixed mode, and a hydrophobic interaction resin.

18. The method of claim 14 , wherein the separation matrix is an affinity resin selected from the group consisting of: Protein A, Protein G, and a synthetic mimetic affinity resin.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 18, 2019
From: SHULTZ, JOSEPH EDWARD; HART, ROGER
To: AMGEN INC.
Reel/Frame 051320/0612 →
Continuity (5)
Continuation 15476691 · Mar 31, 2017
Continuation 14599336 · Jan 16, 2015
Division 12822990 · Jun 24, 2010
Provisional Application 61220477 · Jun 25, 2009
Related Publication 20200361986A1 · Nov 19, 2020